A simple and efficient new approach to the total synthesis of (±)-4- amino-3-(4-chlorophenyl)-butyric acid (BACLOFEN)

Synthetic Communications

Volumn 27, Issue 14, 1997, Pages 2455-2465

  Coelho, Fernando ^a   De Azevedo, Mariangela B M ^a   Boschiero, Roberta ^a   Resende, Patrícia ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR; BACLOFEN;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; DRUG HYDROLYSIS; DRUG SYNTHESIS; PROTON NUCLEAR MAGNETIC RESONANCE; SPASTICITY;

EID: 0030958444     PISSN: 00397911     EISSN: None     Source Type: Journal    
DOI: 10.1080/00397919708004109     Document Type: Article

References (37)

1. a) Bowery, N.G., Hudson, A.L. and Price, G.W. Neuroscience, 1987, 20, 365;
2. b) Nicoll, R.A. Science, 1988, 241, 545;
3. c) Hill, D.R. and Bowery, N.G. Nature, (London), 1981, 290, 149.
4. Mann, A., Boulanger, T., Brandau, B., Durant, F., Evrard, G., Heaulme, M., Desaules, E. and Wermuth, C.-G. J. Med. Chem., 1991, 34, 1307.
5. Bowery, N G and Williams, L.G. Br. J. Pharmacol., 1986, 87, 37P.
6. Bowery, N.G. Trends Pharmacol. Sci., 1982, 400.
7. B Receptors in Mammalian Function," Bowery, N.G.; Bittiger, H.; Olpe, H.-R. Eds.; John Wiley and Sons, Chichester, 1990, p.3.
8. Johnston, GAR Benzodiazepine/GABA receptors and chloride channels. "Receptor Biochemistry and Methodology;" Olsen, R.W.; Veuter, J.C. Eds., A.R. Liss, Inc., New York, 1986, Vol. 5, pp 57-71.
9. a) Kerr, D.I.B. and Ong, J. Med. Res. Revs., 1992, 12, 593;
10. b) Berthelot, P., Vaccher, C., Flouquet, N., Debaert, M., Luyckx, M., Brunet, C. J. Med. Chem., 1991, 34, 2557;
11. c) Kerr, D.I.B., Ong, J., Doolette, D.J., Abbenante, J. and Prager, R.H. Eur. J. Pharmacol., 1989, 96, 239;
12. d) Olpe, H.-R., Demieville, H., Baltzer, V., Bencze, W.L., Koella, W.P., Wolf, P. and Haas, H.L. Eur. J. Pharmacol., 1978, 52, 133.
13. For some examples of racemic synthesis of Baclofen and derivatives see: a) Kerberle, H., Faigle, J.W. and Wilhelm, M. Swiss Patent, 499,046, (Chemical Abstracts, 1968, 69, 106273f); b) Ibuka, T., Schoenfelder, A., Bildstein, P. and Mann, A. Synth. Commun., 1995, 25, 1777; c) Pifferi, G., Nizzola, R. and Cristoni, A. Il Farmaco, 1994, 49, 453 (Chemical Abstracts, 1995, 122, 204918c); d) Wall, G.M. and Baker, J.K. J. Med. Chem., 1989, 32, 1340.
14. For some examples of racemic synthesis of Baclofen and derivatives see: a) Kerberle, H., Faigle, J.W. and Wilhelm, M. Swiss Patent, 499,046, (Chemical Abstracts, 1968, 69, 106273f); b) Ibuka, T., Schoenfelder, A., Bildstein, P. and Mann, A. Synth. Commun., 1995, 25, 1777; c) Pifferi, G., Nizzola, R. and Cristoni, A. Il Farmaco, 1994, 49, 453 (Chemical Abstracts, 1995, 122, 204918c); d) Wall, G.M. and Baker, J.K. J. Med. Chem., 1989, 32, 1340.
15. For some examples of racemic synthesis of Baclofen and derivatives see: a) Kerberle, H., Faigle, J.W. and Wilhelm, M. Swiss Patent, 499,046, (Chemical Abstracts, 1968, 69, 106273f); b) Ibuka, T., Schoenfelder, A., Bildstein, P. and Mann, A. Synth. Commun., 1995, 25, 1777; c) Pifferi, G., Nizzola, R. and Cristoni, A. Il Farmaco, 1994, 49, 453 (Chemical Abstracts, 1995, 122, 204918c); d) Wall, G.M. and Baker, J.K. J. Med. Chem., 1989, 32, 1340.
16. For some examples of racemic synthesis of Baclofen and derivatives see: a) Kerberle, H., Faigle, J.W. and Wilhelm, M. Swiss Patent, 499,046, (Chemical Abstracts, 1968, 69, 106273f); b) Ibuka, T., Schoenfelder, A., Bildstein, P. and Mann, A. Synth. Commun., 1995, 25, 1777; c) Pifferi, G., Nizzola, R. and Cristoni, A. Il Farmaco, 1994, 49, 453 (Chemical Abstracts, 1995, 122, 204918c); d) Wall, G.M. and Baker, J.K. J. Med. Chem., 1989, 32, 1340.
17. For some examples of racemic synthesis of Baclofen and derivatives see: a) Kerberle, H., Faigle, J.W. and Wilhelm, M. Swiss Patent, 499,046, (Chemical Abstracts, 1968, 69, 106273f); b) Ibuka, T., Schoenfelder, A., Bildstein, P. and Mann, A. Synth. Commun., 1995, 25, 1777; c) Pifferi, G., Nizzola, R. and Cristoni, A. Il Farmaco, 1994, 49, 453 (Chemical Abstracts, 1995, 122, 204918c); d) Wall, G.M. and Baker, J.K. J. Med. Chem., 1989, 32, 1340.
18. For some examples of asymmetric synthesis of (-)-Baclofen and derivatives see: a) Chênevert, R. and Desjardins, M. Tetrahedron. Lett., 1991, 32, 4249; Chênevert, R. and Desjardins, M., Can. J. Chem., 1994, 72, 2312; b) Herdeis, C. and Hubmann, H.P. Tetrahedron Asymmetry, 1992, 3, 1213; c) Schoenfelder, A., Mann, A. and Le Coz, S. Synlett, 1993, 63; d) Prager, R.H., Schafer, K., Hamon, D.P.C. and Massy-Westropp, R.A. Tetrahedron, 1995, 51,11465; e) Yoshifuji, S., Kaname, M., Chem. Pharm. Bull., 1995, 43, 1302.
19. For some examples of asymmetric synthesis of (-)-Baclofen and derivatives see: a) Chênevert, R. and Desjardins, M. Tetrahedron. Lett., 1991, 32, 4249; Chênevert, R. and Desjardins, M., Can. J. Chem., 1994, 72, 2312; b) Herdeis, C. and Hubmann, H.P. Tetrahedron Asymmetry, 1992, 3, 1213; c) Schoenfelder, A., Mann, A. and Le Coz, S. Synlett, 1993, 63; d) Prager, R.H., Schafer, K., Hamon, D.P.C. and Massy-Westropp, R.A. Tetrahedron, 1995, 51,11465; e) Yoshifuji, S., Kaname, M., Chem. Pharm. Bull., 1995, 43, 1302.
20. For some examples of asymmetric synthesis of (-)-Baclofen and derivatives see: a) Chênevert, R. and Desjardins, M. Tetrahedron. Lett., 1991, 32, 4249; Chênevert, R. and Desjardins, M., Can. J. Chem., 1994, 72, 2312; b) Herdeis, C. and Hubmann, H.P. Tetrahedron Asymmetry, 1992, 3, 1213; c) Schoenfelder, A., Mann, A. and Le Coz, S. Synlett, 1993, 63; d) Prager, R.H., Schafer, K., Hamon, D.P.C. and Massy-Westropp, R.A. Tetrahedron, 1995, 51,11465; e) Yoshifuji, S., Kaname, M., Chem. Pharm. Bull., 1995, 43, 1302.
21. For some examples of asymmetric synthesis of (-)-Baclofen and derivatives see: a) Chênevert, R. and Desjardins, M. Tetrahedron. Lett., 1991, 32, 4249; Chênevert, R. and Desjardins, M., Can. J. Chem., 1994, 72, 2312; b) Herdeis, C. and Hubmann, H.P. Tetrahedron Asymmetry, 1992, 3, 1213; c) Schoenfelder, A., Mann, A. and Le Coz, S. Synlett, 1993, 63; d) Prager, R.H., Schafer, K., Hamon, D.P.C. and Massy-Westropp, R.A. Tetrahedron, 1995, 51,11465; e) Yoshifuji, S., Kaname, M., Chem. Pharm. Bull., 1995, 43, 1302.
22. For some examples of asymmetric synthesis of (-)-Baclofen and derivatives see: a) Chênevert, R. and Desjardins, M. Tetrahedron. Lett., 1991, 32, 4249; Chênevert, R. and Desjardins, M., Can. J. Chem., 1994, 72, 2312; b) Herdeis, C. and Hubmann, H.P. Tetrahedron Asymmetry, 1992, 3, 1213; c) Schoenfelder, A., Mann, A. and Le Coz, S. Synlett, 1993, 63; d) Prager, R.H., Schafer, K., Hamon, D.P.C. and Massy-Westropp, R.A. Tetrahedron, 1995, 51,11465; e) Yoshifuji, S., Kaname, M., Chem. Pharm. Bull., 1995, 43, 1302.
23. For some examples of asymmetric synthesis of (-)-Baclofen and derivatives see: a) Chênevert, R. and Desjardins, M. Tetrahedron. Lett., 1991, 32, 4249; Chênevert, R. and Desjardins, M., Can. J. Chem., 1994, 72, 2312; b) Herdeis, C. and Hubmann, H.P. Tetrahedron Asymmetry, 1992, 3, 1213; c) Schoenfelder, A., Mann, A. and Le Coz, S. Synlett, 1993, 63; d) Prager, R.H., Schafer, K., Hamon, D.P.C. and Massy-Westropp, R.A. Tetrahedron, 1995, 51,11465; e) Yoshifuji, S., Kaname, M., Chem. Pharm. Bull., 1995, 43, 1302.
24. Tidwell, T.T., Ketenes; Wiley-Insterscience, New York, 1995.
25. For a recent discussion about the mechanism of [2+2] cycloaddition of dichloroketenes see: a) Hyatt, J.A. and Raynolds, P.W. Org. React. 1994, 45, 159-646; b) Valenti, E., Pericàs, M.A. and Moyano, A. J. Org. Chem., 1990, 55, 3582; c). Wang, X. and Houk, K.N. J. Am. Chem. Soc., 1990, 112, 1754.
26. For a recent discussion about the mechanism of [2+2] cycloaddition of dichloroketenes see: a) Hyatt, J.A. and Raynolds, P.W. Org. React. 1994, 45, 159-646; b) Valenti, E., Pericàs, M.A. and Moyano, A. J. Org. Chem., 1990, 55, 3582; c). Wang, X. and Houk, K.N. J. Am. Chem. Soc., 1990, 112, 1754.
27. For a recent discussion about the mechanism of [2+2] cycloaddition of dichloroketenes see: a) Hyatt, J.A. and Raynolds, P.W. Org. React. 1994, 45, 159-646; b) Valenti, E., Pericàs, M.A. and Moyano, A. J. Org. Chem., 1990, 55, 3582; c). Wang, X. and Houk, K.N. J. Am. Chem. Soc., 1990, 112, 1754.
28. a) Olah, G.A. and Fung, A.P. Synthesis, 1979, 537;
29. b) Laurent, A., Jacquault, P., Di Martino, J.-L. and Hamelin, J. J. Chem Soc. Chem. Commun., 1995, 1101.
30. Brooks, L.A. J. Am. Chem. Soc., 1944, 66, 1295.
31. Borka, L. Acta Pharm. Suec., 1979, 16, 345 (Chemical Abstracts, 1980, 92, 82536r)
32. Borka, L. Acta Pharm. Suec., 1979, 16, 345 (Chemical Abstracts, 1980, 92, 82536r)
33. a) Staudinger, H. Chem. Ber., 1905, 35, 1735;
34. b) Smith, C.W., Norton, D.G. Organic-Synthesis, Coll. Vol. IV, 1963, 348;
35. c) McCaney, C.C., Ward, R.S. J. Chem. Soc. Perkin Trans I, 1975, 1600;
36. d) For the activation of zinc see: Tsuda, K.; Ohki, E.; Nozoe, S. J Org. Chem., 1963, 28, 783;
37. e) For the preparation of the couple Zn-Cu see: Brady, W.T.; Liddell, H.G.; Vaughan, W.L. J. Org. Chem., 1966, 31, 626.